CCL20 and pancreatic ductal adenocarcinoma: In various tumor entities, such as cervical carcinoma, pancreatic ductal adenocarcinoma, cutaneous squamous cell carcinoma and breast cancer, a high expression of CCL20 in the tumor tissue was associated with tumor progression [11,12,13,14].